Skip to content

Clinical trials

Recruiting Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Recruiting Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20193
20201
20211
20227
202313
20247
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Pulmonary Hospital, Shanghai, China6
Fudan University5
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2
Jonsson Comprehensive Cancer Center2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Anusha Kalbasi1
AstraZeneca1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo1
Duboce Biopharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung47
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms13
Pancreatic Neoplasms5
Ovarian Neoplasms4
Carcinoma, Transitional Cell3
Colorectal Neoplasms3
Esophageal Neoplasms3
Breast Neoplasms2
Endometrial Neoplasms2

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.